Furthermore, serum SPP1 levels are increased in COPD patients with frequent exacerbations and during acute exacerbations, suggesting its potential as a biomarker for monitoring disease activity and exacerbation risk [85,86]. Here, SPP1 is linked to chronic obstructive pulmonary disease.